Aims
Arrhythmogenic Ca 2+ waves result from uncontrolled Ca 2+ release from the sarcoplasmic reticulum (SR) that occurs with increased Ca 2+ sensitivity of the ryanodine receptor (RyR) or excessive Ca 2+ accumulation during b-adrenergic stimulation. We hypothesized that inhibition of the L-type Ca 2+ current (I CaL ) could prevent such Ca 2+ waves in both situations. transient is not prevented, and merits further study to understand the full antiarrhythmic potential of I CaL inhibition. 4 We hypothesized that reduced influx 
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Material and methods
See Supplementary material online for detailed description.
Animals and cell isolation
This investigation was approved by the Norwegian Animal Research Committee and conforms to the Directive 2010/63/EU of the European Parliament. Male C57Bl6 and ankyrin B KO mice (8 -12 weeks, 25 -30 g) were used. 9 Left ventricular cardiomyocytes were isolated by enzymatic digestion. 14 
Experimental conditions
Beta-adrenergic receptor (b-AR) stimulation was induced by exposure to 0.1 mM isoproterenol sulphate (ISO) for a minimum of 1 min. RyR Ca 2+ sensitivity was increased by adding 500 or 1000 mM caffeine to the superfusate. I CaL inhibition was attained with 0.5 mM verapamil or 1.0 mM nicardipine treatment for 3 -6 min. All experiments were performed at 37.08C.
Ca 21 measurements
Myocytes loaded with fluo-4 AM ester were superfused with a modified 
Field stimulation
Myocytes were field stimulated with platinum electrodes at 1 Hz by a 3 ms symmetrical bipolar pulse, 25% above threshold.
Electrophysiology
The I -V relationship for I CaL was determined using whole- 
Protein phosphorylation
The effect of verapamil on phosphorylation of key Ca 2+ handling proteins was tested by perfusing excised hearts at 37.08C for 2 min on a Langendorff setup with solution A containing 0.1 mM ISO + 0.5 mM verapamil. Hearts were then removed from the cannula, and the left ventricle was dissected and immediately frozen on liquid N 2 . Phosphorylation status was determined using western blotting.
Computational modelling
A mathematical model was employed to study the effects of verapamil on Ca 2+ homeostasis. 16 The that govern the direction and magnitude of transmembrane ion fluxes in cardiomyocytes. In the model, verapamil addition was assumed to positively affect the rate of transition from the closed active to the closed inactive state of the LTCC, whereas ISO was assumed to positively affect the opposite rate of transition as well as the affinity of the SERCA pump.
Statistics
Mean data were compared by using Student's t-test. Figure 1B and C, respectively). I CaL inhibition with 0.5 mM verapamil under these conditions reduced the probability of Ca 2+ waves to 6% (P , 0.05) during stimulation and 21% (P , 0.05) in the rest period. Furthermore, the frequency of Ca 2+ waves in the rest period also decreased with verapamil (ISO + caffeine vs. ISO + caffeine + verapamil: 0.37 + 0.12 vs. 0.02 + 0.01 waves s -1 , P , 0.05, Figure 1D ).
The protective effect of verapamil against Ca 2+ waves was also tested by further increasing RyR Ca 2+ sensitivity using higher caffeine concentration (1000 mM). Even in these conditions, verapamil reduced the Ca 2+ wave probability during stimulation (P , 0.05, Figure 1B ) and the frequency of Ca 2+ waves in the rest period (P , 0.05, Figure 1D ). Verapamil was also effective in preventing Ca To test the generalizability of our findings with verapamil, we performed similar experiments with another LTCC antagonist from a different pharmacological group, i.e. the dihydropyridine nicardipine. The preventive effect on Ca 2+ waves in the rest period was comparable with verapamil (Supplementary material online, Figure S1E -G). Interestingly, in all of the above experiments, we observed an additional category of abnormal Ca 2+ release during the decay phase of the Ca 2+ transient ( Figure 1 and Supplementary material online, Figure S2 ). These events were termed 'early Ca 2+ release events' since they could be clearly separated from Ca 2+ waves (Supplementary material online, Figure S2A and B). The occurrence of early Ca 2+ release showed a time-dependent increase during ISO stimulation (Supplementary material online, Figure S2C ), and did not occur in voltage-clamped cells exposed to K + -current blockers (Supplementary material online, Figure S2D ). Notably, this type of Ca 2+ release
was not prevented by I CaL inhibition ( Figure 1E , Supplementary material online, Figure S1D and H). In a multiple regression analysis, the occurrence of early Ca 2+ release events did not affect the probability for sparks or by hampered wave propagation. Therefore, we investigated the effect of I CaL inhibition on the initiating Ca 2+ sparks by confocal microscopy ( Figure 2 ). As expected, combined ISO and 500 mM caffeine increased the frequency of sparks compared with control conditions (+3030 + 837%, P , 0.05, Figure 2B ). I CaL inhibition under these conditions reduced the Ca 2+ spark frequency by 80 + 17% (P , 0.05). In these experiments, Ca 2+ waves occurred in 62% of the cells at rest after stimulation and ISO + caffeine exposure, but were completely abolished by verapamil (P , 0.05, Figure 2C ). Thus, I CaL inhibition prevented Ca 2+ wave initiation.
I CaL inhibition reduces [Ca 21 ] SR during b-AR stimulation
Having established that I CaL inhibition is a useful strategy for preventing Ca 2+ waves, we further examined the underlying mechanism. Our first step in this analysis was to quantify the degree of I CaL inhibition obtained by the chosen verapamil concentration. This was analysed from measurements of the current -voltage (I -V ) relationship for I CaL during verapamil exposure in the absence and presence of b-AR stimulation ( Figure 3A) . To mimic the conditions in the field stimulation experiments used for induction of waves, we used preconditioning pulses with voltage steps from 270 to 0 mV. As expected, b-AR stimulation resulted in a leftward shift of the I -V relationship, while verapamil reduced peak I CaL at all voltage steps ( Figure 3B ). Figure 3D ). frequency of Ca 2+ sparks ( Figure 4A and B) . From this we conclude that the effect of verapamil depend on an intact sarcolemma. Thus, potential direct effects on RyR did not contribute to the preventive actions of verapamil on Ca 2+ sparks and waves.
Another possible explanation for reduced Ca 2+ wave probability during I CaL inhibition is reduced activity of Ca 2+ -calmodulindependent kinase type II (CaMKII). CaMKII activity is increased by b-AR stimulation, and increased I CaL is a possible contributor to this effect. 18 Since CaMKII is known to increase the risk for Ca 2+ waves, verapamil could potentially reduce Ca 2+ wave probability through reduced I CaL -dependent CaMKII activation. We tested this possibility by measuring phosphorylation levels of key PKA-and CaMKII-dependent phosphorylation sites on phospholamban (PLB)
and RyR in left ventricles from hearts perfused with ISO in the presence and absence of verapamil. Verapamil did not alter phosphorylation status of either PLB or RyR ( Figure 4C ). Thus, alterations in PKA-or CaMKII-dependent phosphorylation did not contribute to reduced Ca 2+ wave probability from I CaL inhibition. during ISO exposure compared with C57Bl6 (WT) ( Figure 6A -E, P , 0.05 for all data). The effect of verapamil exposure was then tested in ankyrin B KO cardiomyocytes with the same protocol as used for our caffeine experiments ( Figure 6F ). ISO exposure resulted in Ca 2+ waves during field stimulation in 35% of ankyrin B KO cardiomyocytes, while 69% exhibited waves during the following 10 s rest period ( Figure 6G ). Verapamil completely abolished Ca 2+ waves during stimulation (P , 0.05) and reduced the probability to 29% during the rest period (P , 0.05), with a 60 + 15% decrease in frequency (0.20 + 0.04 vs. 0.08 + 0.03 waves s 21 , P , 0.05). In whole-cell voltage-clamped cells exposed to ISO, verapamil reduced I CaL by 71 + 6% ( Figure 6I) . Importantly, this resulted in a 19 + 5% decrease in [Ca 2+ ] SR ( Figure 6J) . Thus, the wave preventive mechanism of verapamil found in our experiments with caffeine was also applicable to cardiomyocytes from ankyrin B KO mice.
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Discussion
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2+ waves, we observed that the LTCC antagonists used in our experiments did not prevent early Ca 2+ release events. 
Prevention of arrhythmogenic
The Ca 21 wave preventive effect of verapamil depends on an intact sarcolemma
A direct effect from verapamil on RyR has been suggested since it was found that verapamil could bind directly to RyR in skeletal muscle. However, Galimberti and Knollmann found that a very high concentration of verapamil (.20 mM) was needed to inhibit Ca 2+ sparks in permeabilized cardiomyocytes. 17 We found that 0.5 mM verapamil did not affect Ca 2+ spark frequency in permeabilized cells, indicating that the effects of verapamil seen in our experiments depend on an intact sarcolemma, and were not due to direct effects on RyR. Indeed, in cells with intact sarcolemma and functioning LTCCs, we found a decrease in spark frequency. We therefore conclude that a direct effect on RyR did not contribute to the preventive effect of verapamil in our study. This is in accordance with results in a previous study, 26 and was supported by our computational modelling, which showed that lone I CaL inhibition is sufficient to reduce [Ca 2+ ] SR in the presence of ISO.
Limitations and clinical perspectives
The focus in this study is strictly experimental, aiming to further understand Ca 2+ cycling during Ca 2+ wave development and explore potential therapeutic targets. In a clinical perspective, three features of I CaL inhibition in general and by verapamil specifically are important. First, LTCC antagonists have a potentially negative inotropic effect. Therefore, we have limited our study to models mimicking conditions with preserved contractility. Secondly, verapamil is primarily a 'usedependent' LTCC antagonist relying on activation of the channel for binding. Therefore, with increased activation frequency occurring with b-AR stimulation in vivo, one could speculate that the inhibitory effect of verapamil would be even more pronounced than in our study where cells were paced at 1 Hz. As discussed above, the level of I CaL inhibition needed to obtain antiarrhythmic effects, yet still avoid contractile impairment, is unknown. Thirdly, verapamil has been shown to also inhibit K + -currents. 27 Although the impact on human ventricular cardiomyocytes is uncertain, this aspect needs to be addressed in order to determine what conditions that might be suitable for I CaL inhibition as antiarrhythmic therapy. This will be especially important for LQTS caused by K + -channel mutations, as the differential distribution of I to throughout the myocardium could predispose to reentry circuits. 28 A further potential limitation to the clinical use of verapamil and nicardipine is that these drugs did not prevent early Ca 2+ release events. Such events occurred to a similar extent both in the absence and in the presence of I CaL inhibition (Supplementary material online, Figures S1D and H, and S2C) . Therefore, their occurrence during exposure to verapamil or nicardipine is not an effect of these drugs.
Although our experiments were not designed to address the mechanism underlying the early Ca 2+ release events, they could be clearly separated from the diastolic Ca 2+ waves that were the focus of our study. Our confocal microscopy linescan images clearly show that these events do not occur as propagating waves, but rather as homogeneous increases in [Ca 2+ ] across the cell (Supplementary material online, Figure S2 ). 
Supplementary material
Supplementary material is available at Cardiovascular Research online.
